Fig. 2From: Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trialResults of two-factor repeated measure ANOVA for comparison of Hamilton depression rating scale scores (mean ± SEM) over time between the empagliflozin (Treatment) Group and placebo groupBack to article page